These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 9509216)

  • 1. Platelet transfusion for surgery in the presence of polycythemia vera.
    Terasako K; Sasai S
    Acta Anaesthesiol Scand; 1998 Feb; 42(2):270-1. PubMed ID: 9509216
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cerebral Hemorrhage of a 50-Year-Old Female Patient with Polycythemia Vera.
    Chen L; Xiao H; Hu Z
    J Stroke Cerebrovasc Dis; 2019 Aug; 28(8):e110-e112. PubMed ID: 31126786
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anesthesia for polycythemia vera.
    Sosis MB
    J Clin Anesth; 1990; 2(1):31-4. PubMed ID: 2178645
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anticoagulant-resistant thrombophilia in a patient with polycythemia vera: a case report.
    Das S; Karachiwala H; Cherian SV; Garcha AS; Jasti S; Gajra A
    Blood Coagul Fibrinolysis; 2011 Dec; 22(8):746-8. PubMed ID: 21885951
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Treatment with hydroxyurea of polycythemia vera in a 11 year-old child].
    Vodoff MV; Nelken B; Vic P; Farriaux JP
    Arch Pediatr; 1996 Sep; 3(9):870-3. PubMed ID: 8949347
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiovascular events and intensity of treatment in polycythemia vera.
    Marchioli R; Finazzi G; Specchia G; Cacciola R; Cavazzina R; Cilloni D; De Stefano V; Elli E; Iurlo A; Latagliata R; Lunghi F; Lunghi M; Marfisi RM; Musto P; Masciulli A; Musolino C; Cascavilla N; Quarta G; Randi ML; Rapezzi D; Ruggeri M; Rumi E; Scortechini AR; Santini S; Scarano M; Siragusa S; Spadea A; Tieghi A; Angelucci E; Visani G; Vannucchi AM; Barbui T;
    N Engl J Med; 2013 Jan; 368(1):22-33. PubMed ID: 23216616
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk of thrombosis according to need of phlebotomies in patients with polycythemia vera treated with hydroxyurea.
    Alvarez-Larrán A; Pérez-Encinas M; Ferrer-Marín F; Hernández-Boluda JC; Ramírez MJ; Martínez-López J; Magro E; Cruz Y; Mata MI; Aragües P; Fox ML; Cuevas B; Montesdeoca S; Hernández-Rivas JA; García-Gutiérrez V; Gómez-Casares MT; Steegmann JL; Durán MA; Gómez M; Kerguelen A; Bárez A; García MC; Boqué C; Raya JM; Martínez C; Albors M; García F; Burgaleta C; Besses C;
    Haematologica; 2017 Jan; 102(1):103-109. PubMed ID: 27686377
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of polycythemia vera with hydroxyurea.
    Sharon R; Tatarsky I; Ben-Arieh Y
    Cancer; 1986 Feb; 57(4):718-20. PubMed ID: 3943010
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polycythemia vera and pregnancy: a case report with the use of hydroxyurea in the first trimester.
    Pata O; Tok CE; Yazici G; Pata C; Oz AU; Aban M; Dilek S
    Am J Perinatol; 2004 Apr; 21(3):135-7. PubMed ID: 15085495
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Erythromelalgia and vascular complications in polycythemia vera.
    Michiels JJ
    Semin Thromb Hemost; 1997; 23(5):441-54. PubMed ID: 9387203
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Laboratory investigations and prediction of thrombotic risk in polycythemia vera.
    Boneu B
    Nouv Rev Fr Hematol (1978); 1994 Apr; 36(2):183-5. PubMed ID: 8036139
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polycythemia vera in a 12-year-old girl: a case report.
    Turker M; Ozer EA; Oniz H; Atabay B; Yaprak I
    Pediatr Hematol Oncol; 2002 Jun; 19(4):263-6. PubMed ID: 12051593
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic recommendations in polycythemia vera based on Polycythemia Vera Study Group protocols.
    Berk PD; Goldberg JD; Donovan PB; Fruchtman SM; Berlin NI; Wasserman LR
    Semin Hematol; 1986 Apr; 23(2):132-43. PubMed ID: 3704665
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An exceptional case of renal artery restenosis in a patient with polycythaemia vera.
    Gavriilaki E; Sampanis N; Kavlakoudis C; Papaioannou G; Vasileiou S
    Blood Coagul Fibrinolysis; 2014 Dec; 25(8):904-6. PubMed ID: 24991947
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The rate of progression to polycythemia vera or essential thrombocythemia in patients with erythrocytosis or thrombocytosis.
    Ruggeri M; Tosetto A; Frezzato M; Rodeghiero F
    Ann Intern Med; 2003 Sep; 139(6):470-5. PubMed ID: 13679323
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Qualitative platelet defect and thrombohaemorrhagic complications in a patient with polycythaemia vera. Case 10.
    Friess D; Lämmle B; Alberio L
    Hamostaseologie; 2003 Aug; 23(3):138-43. PubMed ID: 12923585
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of hydroxyurea on PRV-1 expression in patients with essential thrombocythemia and polycythemia vera.
    Johansson P; Ricksten A; Wasslavik C; Johansson B; Andréasson B
    Haematologica; 2004 Oct; 89(10):1264-6. PubMed ID: 15477215
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recurrent thrombosis in patients with polycythemia vera and essential thrombocythemia: incidence, risk factors, and effect of treatments.
    De Stefano V; Za T; Rossi E; Vannucchi AM; Ruggeri M; Elli E; Micò C; Tieghi A; Cacciola RR; Santoro C; Gerli G; Vianelli N; Guglielmelli P; Pieri L; Scognamiglio F; Rodeghiero F; Pogliani EM; Finazzi G; Gugliotta L; Marchioli R; Leone G; Barbui T;
    Haematologica; 2008 Mar; 93(3):372-80. PubMed ID: 18268279
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hydroxyurea in the treatment of polycythemia vera: a prospective study of 100 patients over a 20-year period.
    West WO
    South Med J; 1987 Mar; 80(3):323-7. PubMed ID: 3824016
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Polycythemia vera: the disadvantages of overproduction].
    Aumiller J
    MMW Fortschr Med; 2015 Apr; 157(8):18-20. PubMed ID: 26012664
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.